The role of canonical Wnt/β-catenin signaling in postnatal bone growth has not been fully defined. In the present studies, we generated β-catenin conditional knockout (KO) mice and deleted β-catenin in Col2-expressing chondrocytes and mesenchymal progenitor cells. Findings from analyzing the β-catenin Col2CreER KO mice revealed severe bone destruction and bone loss phenotype in epiphyseal bone, probably due to the increase in osteoclast formation and the accumulation of adipocytes in this area. In addition, we also found bone destruction and bone loss phenotype in vertebral bone in β-catenin Col2CreER KO mice. These findings indicate that β-catenin signaling plays a critical role in postnatal bone remodeling. Our study provides new insights into the regulation of epiphyseal bone homeostasis at postnatal stage.
Introduction
Epiphysis is the terminal section of a growing long bone in mammals. It is separated from the bone shaft (diaphysis) by cartilage. New bone is produced on the side of the cartilage facing the diaphysis, while new cartilage is produced on the other side of the cartilage plate. At the joint, the epiphysis is covered with articular cartilage and a zone of subchondral bone is located below articular cartilage. In young animals, the epiphyses of long bones grow by chondrogenesis within the articular cartilage. A better understanding of the molecular mechanisms that regulate the growth of articular cartilage may give insight into the antecedents of joint disease, such as osteonecrosis (1, 2) .
Canonical Wnt/β-catenin signaling plays a critical role in skeletal development and postnatal bone growth (3) (4) (5) (6) (7) . During skeletal development, activation of β-catenin signaling in limb mesenchymal cells inhibits cartilage development and promotes osteoblast differentiation (3, 4) . β-catenin also induces growth plate chondrocyte differentiation (5) . In mature osteoblasts, β-catenin promotes osteoblast differentiation and inhibits osteoclast formation (6) . Our previous studies indicate that β-catenin expressed in Col2-expressing cells interacts with osteoclast precursor cells and regulates osteoclast formation at the postnatal stage (7) .
Recent lineage tracing studies revealed that cells expressing Cre-recombinases driven by the Col2 promoter/enhancer and their descendants contributed to, in addition to chondrocytes, early perichondrial precursor cells (8) . Similarly, a recent study also demonstrated that hypertrophic chondrocytes can become an osteoblast and contribute to the osteogenic lineage cells (9) . In these studies, a cell-specific tamoxifen-inducible genetic recombination approach was utilized to track the fate of murine hypertrophic chondrocytes and the study showed that hypertrophic chondrocytes can survive the cartilage-to-bone transition and become
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Using Col2-CreER transgenic mice to specifically delete β-catenin in Col2-expressing mesenchymal progenitor cells and chondrocytes, in the present studies we demonstrated that these β-catenin Col2CreER knockout (KO) mice display severe defects in epiphyseal bone, including increased osteoclast formation and accumulation of adipocytes in the marrow cavity. In addition, we also found adipocyte accumulation in the bone marrow underneath the growth plate. We also observed the destruction and bone loss in vertebral bone in β-catenin Col2CreER KO mice. Our studies provide additional evidence of β-catenin signaling in postnatal bone remodeling and bone homeostasis.
Materials and Methods

Animals
Col2-CreER T2 transgenic mice were generated in our lab (10) (11) (12) and ROSA mT/mG and ROSA26R reporter mice (13) were obtained from Jackson Laboratories (Bar Harbor, ME, USA). β-catenin flox/flox mice were originally reported by Brault et al. (14) (obtained from Jackson lab) and we have used these mice in our previous studies (7) . β-catenin Col2CreER mice were generated by breeding β-catenin flox/flox mice with Col2-CreER T2 transgenic mice. Tamoxifen (Sigma, St. Louis, MO, USA) was administered into 2-week-old β-catenin Col2CreER and Cre-negative control mice by intraperitoneal (i.p.) injection (1 mg/l0 g body weight for 5 consecutive days) and mice were sacrificed when they are 3-month-old. The animal protocol of this study has been approved by the IACUC of the Rush University and all experimental methods and procedures were carried out in accordance with the approved guidelines.
Cre-Recombination Efficiency
Col2-CreER T2 mice were bred with ROSA mT/mG and ROSA26R reporter mice to generate Col2-CreER T2 ; ROSA mT/mG and Col2-CreER T2 ; ROSA26R mice. Tamoxifen was administered into 2-week-old mice by i.p. injection (1 mg/l0 g body weight for 5 days). Long bones were dissected after the mice were sacrificed at 4-week-old, fixed in 0.2 % glutaraldehyde at 4°C for 2 days, followed by washing three times with phosphate buffered saline (PBS). Samples were decalcified in 14% EDTA for 3 weeks, cryo-protected in 30% sucrose at 4°C for 3 days, and then embedded and processed for frozen sections. Three μm thick sections were used for lacZ staining.
Micro-CT Analysis
In 3-month-old Col2-CreER T2 and Cre-negative control mice, quantitative μCT analysis was performed on a VivaCT 40 Scanner (Scanco Medical) at a resolution of 10 μm. Briefly, scanning in the femur/tibia began approximately at the proximal femur, and then extended proximally for 600 slices (10-μm thickness for each slice). Morphometric analysis was performed on 100 slices extending proximally. The 3-dimensional structure and morphometry were reconstructed and analyzed.
Histologic and Histomorphometric Analyses
We dissected long bones from β-catenin Col2CreER mice, and their corresponding Cre-negative control mice. Samples were fixed in 10% neutral buffered formalin (VWR, Radnor, PA, USA) for 3 days, decalcified with formic acid (Decal Chemical Corp., Suffern, NY, USA) for 14 days. Samples were processed and embedded in paraffin. Three μm thick mid-sagittal sections at 3 different levels (50 μm apart) were cut from the medial compartment of the long bone. The sections were stained with Safranin O/fast green (SO/FG), Alcian blue/H&E Orange G (AB/H&E-OG) and tartrate resistant acid phosphatase (TRAP) for morphologic analysis. Three slides per mouse, 6 mice per group, were analyzed in the experiment. Histomorphometric analysis was performed using the OsteoMeasure system (OsteoMetrics, Decatur, GA).
Bone Marrow Stromal Cell Culture
Bone marrow stromal (BMS) cells were isolated from 3-month-old Cre-negative control and β-catenin Col2CreER KO mice or from 3-month-old β-catenin flox/flox mice which were infected with Ad-CMV-Cre or Ad-CMV-GFP (control virus), as described previously (15, 16) . The BMS cells were cultured with osteoblast differentiation medium for 3 days and β-catenin protein levels and mRNA expression of osteoblast marker genes, such as Runx2, Col1a1, alkaline phosphatase (Alp), bone sialoprotein (BSP) and osteocalcin (OC) was analyzed by real-time polymerase chain reaction (PCR) analysis. The cells were also cultured with adipocyte differentiation medium for 3 days and expression of adipocyte marker genes, such as PPAR-γ and cEBP-α, was also analyzed by real-time PCR analysis. Total RNA was prepared using a PureLink RNA Mini kit (Invitrogen) according to the manufacturer's protocol.
Statistical Analysis
The values are presented as mean ± standard error. Statistical difference between groups was evaluated by Student's t-test with SPSS13.0 statistical software. *P < 0.05 and **P < 0.01 were considered as significant difference between groups. (Fig. 1A , white arrowheads). We also bred Col2a1-CreER T2 mice with ROSA26R reporter mice to generate Col2-CreER T2 ; ROSA26R mice. Similarly, tamoxifen was given to the mice at 2-week-old and bone samples were collected at 4-week-old. The results of lacZ staining revealed no recombination was found in growth plate and articular chondrocytes in Cre-negative mice (Fig. 1B,  left panel) . The blue-labelled chondrocytes in Col2-CreER T2 ; ROSA26R mice showed Col2-expressing cells in articular cartilage and growth plate cartilage (Fig. 1B, right panel) . The role of β-catenin in epiphyseal bone was first investigated by X-ray radiographic analysis in β-catenin Col2CreER mice. Tamoxifen was given to 2-week-old mice and the mice were analyzed by X-ray at 3 months of age. The size of β-catenin Col2CreER KO mice was similar to Cre-negative control mice (data not shown), suggesting that β-catenin has no significant effect on bone growth at postnatal stage.
Results
High Cre-Recombination Efficiency of
Specific Deletion of β-Catenin in
Col2-Expressing Cells Leads to Defects of Epiphyseal Bone
Micro-CT analysis revealed significant bone loss and marked bone destruction in the epiphyseal area in 3-month-old β-catenin Col2CreER KO mice ( Fig. 2A,  yellow arrowheads) . In comparison to Cre-negative control mice, bone volume (%, BV/TV) was significantly reduced in β-catenin Col2CreER KO mice (*P < 0.05; n = 6) (Fig. 2B) . Consistent results were also obtained when other bone structure parameters were analyzed by μCT. The connectivity density was significantly reduced (Fig. 2C ) (**P < 0.01; n = 6) and structural model index was significantly increased in β-catenin Col2CreER KO mice (*P < 0.05; n = 6) (Fig. 2D) .
Deletion of β-Catenin in Col2-Expressing Cells Leads to Increased Osteoclast and Adipocyte Formation
To determine the mechanism of bone loss in epiphyseal area of β-catenin Col2CreER KO mice, we performed histological analysis using histology sections derived from 3-month-old β-catenin Col2CreER KO and Cre-negative control mice. Histological analysis of Safranin O/fast green (SO/FG) and Alcian/H&E Orange G (AB/HE-OG) stained sections showed a significant bone loss and accumulation of adipocytes in bone marrow, especially in the area below the growth plate ( Fig. 3A and B) . To determine changes in osteoclast formation, we performed TRAP staining and found that TRAP-positive osteoclast formation was significantly increased in β-caten in Col2CreER KO mice (Fig. 3C) . Black arrowheads marked TRAP-positive osteoclasts and yellow arrowheads marked adipocytes. Consistent with the μCT findings, results of histomorphometric analysis also showed a significantly reduced bone volume and osteoblast numbers in β-catenin Col2CreER KO mice ( Fig. 3D and E) . In contrast, osteoclast numbers were significantly increased in β-catenin Col2CreER KO mice (Fig. 3F) . To further analyze adipocyte formation, we isolated BMS cells and cultured these cells in the presence of adipocyte differentiation medium. We found that more adipocytes were formed in cultured cells derived from β-catenin Col2CreER KO mice (Fig. 3G) . Expression of PPAR-γ and cEBP-α, two adipocyte differentiation markers, was significantly increased in the cells derived from β-catenin Col2CreER KO mice (Fig.  3H) . We then isolated BMS cells from β-catenin flox/flox mice and infected these cells with Ad-CMV-Cre. In the BMS cells with β-catenin in vitro deletion, β-catenin levels were very low and expression of PPAR-γ and cEBP-α was much higher in β-catenin deficient cells (Fig. 3I and J) .
Deletion of β-Catenin in Col2a1-Expressing Cells Leads to Defects of Vertebrae
In addition to long bone, we also analyzed changes in vertebral bone in β-catenin Col2CreER KO mice using μCT technique. Similar to the results found in epiphyseal bone, bone destruction and bone loss phenotype was found in L4-5 of vertebral bones of β-catenin Col2CreER KO mice (Fig. 4 , right panel, red and yellow arrowheads).
Specific Deletion of β-Catenin in
Col2a1-Expressing Cells Inhibited Osteoblast Differentiation
To determine if osteoblast differentiation is altered in β-catenin Col2CreER KO mice, we isolated BMS and examined ALP staining and expression of osteoblast marker genes. No significant changes in ALP activity and expression of osteoblast marker genes were found in β-catenin Col2CreER KO mice (data not shown). To further determine the effects of β-catenin in Col2-expressing cells, we isolated BMS cells from β-catenin flox/flox mice and infected these cells with Ad-CMV-Cre or Ad-CMV-GFP (control virus). We found that β-catenin protein levels were significantly decreased (Fig. 5A) . Expression of osteoblast marker genes, including Runx2, Col1a1, alkaline phosphatase (Alp), bone sialoprotein (BSP) and osteocalcin (OC) was significantly decreased in β-catenin deficient BMS cells (Fig. 5 B-F) , suggesting that osteoblast differentiation was inhibited by deletion of β-catenin.
To summarize the effects of β-catenin in epiphyseal bone, we found that β-catenin inhibits osteoclast and adipocyte formation and promotes osteoblast differentiation (Fig. 6 ).
Discussion
In this study, we generated β-catenin Col2CreER mouse model and demonstrated that deletion of β-catenin in Col2-expressing cells leads to severe defects in epiphyseal bone in β-catenin Col2CreER KO mice. Based on our studies and studies reported by other groups, the Col2-expressing cells not only include chondrocytes but also include mesenchymal progenitor cells (10) (11) (12) 8) . It has been reported that β-catenin plays a critical role in directing mesenchymal cell differentiation into different lineages of cells (3, 4) . Our previous (7) formation in epiphyseal area, suggesting that β-catenin in Col2-expressing cells plays a critical in regulation of osteoclast formation and is responsible for bone destruction under disease conditions. Osteonecrosis is bone death caused by poor blood supply. It is most common in the hip and shoulder, but can affect other large joints such as the knee, elbow, wrist and ankle. After long period of lacking blood supply, the bone can collapse. If osteonecrosis is not treated, the joint deteriorates, leading to severe arthritis. Osteonecrosis can be caused by disease or by severe trauma, such as a fracture or dislocation that affects the blood supply to the bone. In osteonecrosis bone, increased osteoclast formation can be observed which leads to bone destruction (17) . However, administration of anti-bone resorption drugs, such as bisphosphonates, has also been shown often causing osteonerosis of the Jaw (18, 19) . Accumulation of adipocytes in subchondral area of epiphyseal bone is also observed in patients with osteonecrosis (20, 21) . Although the mechanism of β-catenin signaling in the pathogenesis of osteonecrosis has not been fully defined, it has already shown that activation of β-catenin signaling by Lithium chloride could relieve osteonecrosis of femoral head by promoting osteoblast differentiation and inhibiting adipocyte formation (22, 23) .
In addition to the effects on long bone, β-catenin KO mice also showed severe defects in vertebral bone, suggesting that β-catenin also plays a role in vertebral bone remodeling. Our previous study indicates that Col2-expressing cells are mainly located in the inner annulus fibrosus cells and growth plate cartilage cells in the intervertebral disc tissue (24) . It is possible that Col2-expressing cells in growth plate cartilage area in disc tissues could migrate into the vertebral bone and transdifferentiate into osteoblast lineage cells, similar to the Col2-expressing cells in growth plate of long bone. The bone loss phenotype observed in vertebral bone may be due to the β-catenin deficiency in these cells. In β-catenin Col2CreER KO mice, Rankl expression was increased and Opg expression was decreased in Col2-expressing cells (7) . β-catenin could directly act on Opg gene and regulate Opg transcription (6) . β-catenin also regulates Rankl expression through a glucocorticoid receptor (GR)-dependent mechanism (7) . Changes in osteoclast formation observed in the present studies could be due to the combination of up-regulation of RANKL and down-regulation of OPG (7) .
In summary, our study demonstrates that inhibition of β-catenin signaling in Col2-expressing cells could lead to severe defects in long bone, especially in the epiphyseal region and in intervertebral disc, suggesting that β-catenin signaling plays an important role in bone remodeling and bone homeostasis at postnatal stage and in bone and joint diseases. 
